# Phio Pharmaceuticals Corp.: Form 8-K, filed Jan 26, 2024

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2024-01-26
- Accepted by EDGAR: Jan 26, 2024, 17:00 ET
- Period: 2024-01-24
- Accession: 0001683168-24-000489
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/phio_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316824000489/phio_8k.htm

Filed Jan 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-000489. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
